- Home
- CVAC vs DAKT Comparison
CVAC vs DAKT Comparison
Compare CVAC & DAKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- DAKT
- Stock Information
- Founded
- CVAC 2000
- DAKT 1968
- Country
- CVAC Germany
- DAKT United States
- Employees
- CVAC N/A
- DAKT N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- DAKT Office Equipment/Supplies/Services
- Sector
- CVAC Health Care
- DAKT Industrials
- Exchange
- CVAC Nasdaq
- DAKT Nasdaq
- Market Cap
- CVAC 764.4M
- DAKT 680.6M
- IPO Year
- CVAC 2020
- DAKT 1994
- Fundamental
- Price
- CVAC $4.47
- DAKT $14.84
- Analyst Decision
- CVAC Strong Buy
- DAKT Strong Buy
- Analyst Count
- CVAC 2
- DAKT 1
- Target Price
- CVAC $14.00
- DAKT $26.00
- AVG Volume (30 Days)
- CVAC 779.9K
- DAKT 510.2K
- Earning Date
- CVAC 05-20-2025
- DAKT 06-25-2025
- Dividend Yield
- CVAC N/A
- DAKT N/A
- EPS Growth
- CVAC N/A
- DAKT N/A
- EPS
- CVAC 0.87
- DAKT 0.04
- Revenue
- CVAC $566,039,775.00
- DAKT $799,806,000.00
- Revenue This Year
- CVAC N/A
- DAKT N/A
- Revenue Next Year
- CVAC $37.79
- DAKT $4.86
- P/E Ratio
- CVAC $5.16
- DAKT $406.38
- Revenue Growth
- CVAC 787.60
- DAKT N/A
- 52 Week Low
- CVAC $2.37
- DAKT $10.24
- 52 Week High
- CVAC $5.28
- DAKT $19.89
- Technical
- Relative Strength Index (RSI)
- CVAC 65.61
- DAKT 55.21
- Support Level
- CVAC $3.35
- DAKT $15.10
- Resistance Level
- CVAC $4.80
- DAKT $16.14
- Average True Range (ATR)
- CVAC 0.30
- DAKT 0.59
- MACD
- CVAC 0.07
- DAKT -0.05
- Stochastic Oscillator
- CVAC 77.51
- DAKT 36.27
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About DAKT Daktronics Inc.
Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.